Incyte (INCY) Total Debt (2012 - 2026)
Incyte (INCY) reported Total Debt of $39.4 million for Q1 2026, down 5.59% on a YoY basis from $41.7 million in Q1 2025, and down 4.28% quarter-over-quarter from $41.1 million in Q4 2025.
Incyte (INCY) Total Debt (2012 - 2026) Analysis & Trends
Incyte has reported Total Debt for 14 years, with the latest figure at $39.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt fell 5.59% year-over-year to $39.4 million; the trailing twelve-month figure through Mar 2026 stood at $39.4 million (down 5.59% YoY), and the FY2025 full-year result was $41.1 million, up 4.86% from the prior year.
- Total Debt for Q1 2026 stood at $39.4 million, down from $41.1 million in the prior quarter.
- The five-year high for Total Debt was $46.8 million in Q2 2025, with the low at $34.2 million in Q3 2022.
- Historically, Total Debt has averaged $39.1 million across 5 years, with a median of $37.9 million in 2022.
- Annual changes were most pronounced in 2022 — Total Debt retreated 10.55% — and 2025, when it advanced 26.07%.
- Incyte's Total Debt stood at $36.5 million in 2022, then increased by 5.16% to $38.4 million in 2023, then increased by 2.12% to $39.2 million in 2024, then advanced by 4.86% to $41.1 million in 2025, then dropped by 4.28% to $39.4 million in 2026.
- The last three Total Debt figures came in at $39.4 million (Q1 2026), $41.1 million (Q4 2025), and $45.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 39.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.38 Mn |
| Dec 31, 2025 | 41.14 Mn |
| Sep 30, 2025 | 45.62 Mn |
| Jun 30, 2025 | 46.84 Mn |
| Mar 31, 2025 | 41.72 Mn |
| Dec 31, 2024 | 39.24 Mn |
| Sep 30, 2024 | 40.34 Mn |
| Jun 30, 2024 | 37.16 Mn |
| Mar 31, 2024 | 37.16 Mn |
| Dec 31, 2023 | 38.42 Mn |
| Sep 30, 2023 | 36.82 Mn |
| Jun 30, 2023 | 37.51 Mn |
| Mar 31, 2023 | 37.17 Mn |
| Dec 31, 2022 | 36.54 Mn |
| Sep 30, 2022 | 34.19 Mn |
| Jun 30, 2022 | 36.92 Mn |
| Mar 31, 2022 | 37.87 Mn |
| Dec 31, 2021 | 37.01 Mn |
| Sep 30, 2021 | 38.22 Mn |
| Jun 30, 2021 | 39.99 Mn |